Clinical Trials Browser

Completed × Head Neck Cancer Squamous Cell Recurrent × Cetuximab × Clear all

NCT01884623 2024-02-09

ELAN-UNFIT

Phase 3 Completed

Head Neck Cancer Squamous Cell Recurrent